Theralase Reports Decreased Q1 Revenue and Net Loss
Company Announcements

Theralase Reports Decreased Q1 Revenue and Net Loss

Theralase Technologies (TSE:TLT) has released an update.

Theralase Technologies Inc. has reported a 15% drop in total revenue for the first quarter of 2024 compared to the same period last year, with a notable 33% decrease in gross margin. Despite reduced revenues, the company has managed to lower its net loss by 10%, reflecting a decrease in operating expenses across various departments. A conference call is scheduled for June 6th to discuss these financial and operational results in detail.

For further insights into TSE:TLT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskTheralase Plans Extension of Share Purchase Warrants
TipRanks Canadian Auto-Generated NewsdeskTheralase’s Ruvidar Outshines Acyclovir in Herpes Treatment
TipRanks Canadian Auto-Generated NewsdeskTheralase’s Rutherrin® Boosts Lung Cancer Chemotherapy
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App